Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
IM injections take about 5 minutes
Dysregulated metabolism in the pathophysiology of non-allergic obese asthma
Lixisenatide (Adlyxin), which is FDA-approved but no longer marketed in the US, has a half-life of about 3 hours
10.1186/S12933-020-01000-Z 52 SunF.WuS.GuoS.YuK.YangZ.LiL.et al (2015a)
By mimicking the action of natural GLP-1 in the body, these medications help curb hunger signals and reduce food intake, making it easier for individuals to create a calorie deficit and lose weight
Biologic-nave obese patients appear to derive the greatest benefit, while those already on IL-17 or IL-23 inhibitors show more modest additive effects, consistent with a predominantly weight-lossmediated mechanism
US$ 29.40
US$ 26.54
US$ 27.18
